AURA BIOSCIENCES INC's ticker is and the CUSIP is 05153U107. A total of 50 filers reported holding AURA BIOSCIENCES INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $122,970 | -24.7% | 13,709 | +3.7% | 0.00% | 0.0% |
Q2 2023 | $163,279 | +54.1% | 13,221 | +15.8% | 0.00% | 0.0% |
Q1 2023 | $105,940 | +16.4% | 11,416 | +31.7% | 0.00% | 0.0% |
Q4 2022 | $91,014 | -42.4% | 8,668 | -0.4% | 0.00% | 0.0% |
Q3 2022 | $158,000 | +29.5% | 8,700 | +1.4% | 0.00% | 0.0% |
Q2 2022 | $122,000 | +100.0% | 8,577 | +208.3% | 0.00% | – |
Q1 2022 | $61,000 | +24.5% | 2,782 | -4.0% | 0.00% | – |
Q4 2021 | $49,000 | – | 2,897 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Medicxi Ventures Management (Jersey) Ltd | 3,039,892 | $51,617,000 | 12.92% |
Matrix Capital Management Company, LP | 4,112,870 | $69,837,000 | 0.78% |
Rock Springs Capital Management LP | 1,008,114 | $17,118,000 | 0.40% |
Nantahala Capital Management | 99,146 | $1,683,000 | 0.06% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,255,480 | $21,318,000 | 0.04% |
Citadel Advisors | 2,315,102 | $37,318,000 | 0.01% |
CAAS CAPITAL MANAGEMENT LP | 10,000 | $170,000 | 0.00% |
Concord Wealth Partners | 150 | $3,000 | 0.00% |
Allianz Asset Management GmbH | 55,145 | $936,000 | 0.00% |
FMR LLC | 471,300 | $8,003,000 | 0.00% |